Autoimmune Autoantibody Status in Non-autoimmune Encephalopathic Patients

Not Applicable

Completed

• Conditions: Encephalopathy; Autoimmune encephalitis; Metabolic encephalopathy; Hashimoto' s encephalopathy; False positive

• Registration Number: TCTR20201221004
• Lead Sponsor: the Neurogenetics Fund of Ramathibodi Hospital Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-12-31
• Study Start: 2020-12-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

Patients, who admitted at the Ramathibodi Hospital during June to December 2019
Clinical encephalopathy

Exclusion Criteria

Duration of symptoms greater than 3 months
Denied consent

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
False positive antibodies among encephalopathic patients 7 months Blood and CSF test

Secondary Outcome Measures

Name	Time	Method
Comparison of clinical characteristic, investigation data, etiology and outcome between false-positi 7 months hospital record review